Related Experiment Video
Updated: Apr 30, 2026

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.6K
Machine Learning Recognizes Stages of Parkinson's Disease Using Magnetic Resonance Imaging
1Faculty of Computer Science, Polish-Japanese Academy of Information Technology, 86 Koszykowa Street, 02-008 Warsaw, Poland.
Sensors (Basel, Switzerland)
|January 8, 2025
Summary
Machine learning models analyzing brain MRI scans can identify early Parkinson's disease (PD) stages. This study shows structural brain analysis accurately models PD progression, aiding early diagnosis.
Area of Science:
- Neuroimaging
- Machine Learning
- Neurology
Background:
- Neurodegenerative diseases (NDs) like Parkinson's disease (PD) pose a growing global health challenge.
- Early detection of PD is critical for implementing effective intervention strategies.
- Current diagnostic methods may not identify PD in its earliest stages.
Purpose of the Study:
- To investigate the potential of structural analysis of brain regions from T1-weighted MRI scans for modeling PD stages.
- To apply standard machine learning (ML) techniques to differentiate between healthy controls (HC), prodromal (PR), and PD groups.
- To assess the efficacy of using subcortical brain structure volumes and spatial relationships for PD staging.
Main Methods:
- Utilized T1-weighted MRI scans from the PPMI database (N=168).
- Employed machine learning models including Logistic Regression, Random Forest, Support Vector Classifier, and Rough Sets.
- Features included volumes and spatial distances (Euclidean, Cosine) of subcortical structures relative to the thalamus.
Main Results:
- Logistic Regression demonstrated optimal performance with high accuracy (85%), precision (88%), and recall (85%) in PD-stage recognition.
- The models successfully differentiated between HC, PR, and PD groups.
- Interpretable metrics like volume and centroid-based spatial distances contributed to high diagnostic accuracy.
Conclusions:
- Structural analysis of brain regions using MRI and ML offers a promising framework for early PD identification.
- The developed models show significant potential for non-invasive, accurate PD staging.
- This approach could facilitate timely interventions and improve patient outcomes.
Keywords:
Cosine distanceEuclidean distanceParkinson’s disease (PD)machine learning (ML)magnetic resonance imaging (MRI)More Related Videos
Related Concept Videos
Neural Regulation
34.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.7K
Magnetic Resonance Imaging
7.6K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
7.6K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology
26
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
26

